VNDA
Vanda Pharmaceuticals Inc
Price:  
6.18 
USD
Volume:  
357,346.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA WACC - Weighted Average Cost of Capital

The WACC of Vanda Pharmaceuticals Inc (VNDA) is 5.9%.

The Cost of Equity of Vanda Pharmaceuticals Inc (VNDA) is 8.10%.
The Cost of Debt of Vanda Pharmaceuticals Inc (VNDA) is 5.00%.

Range Selected
Cost of equity 6.10% - 10.10% 8.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 6.9% 5.9%
WACC

VNDA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.48 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 10.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 6.9%
Selected WACC 5.9%